United States Pharmaceuticals

Humanigen Inc (HGEN)

Track

Ticker: HGEN Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 18 Oct 2023
Value US$586,180.39 | Price 129.06 | Shares 93,364 (+17.0%)
Sale 18 Oct 2023
Value US$2,407,456.93 | Price 373.43 | Shares 36,319 (+28.7%)
Sale 18 Oct 2023
Value US$376.78 | Price 0.01 | Shares 34,253 (-3.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-20 2023-10-18 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
93,364 +17.0%
129.06
US$586,180 		93,364 +17.0% 129.06 US$586,180
2023-10-20 2023-10-18 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
36,319 +28.7%
373.43
US$2,407,457 		36,319 +28.7% 373.43 US$2,407,457
2023-10-20 2023-10-18 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
94,802 +44.0%
85.54
US$3,966,493 		94,802 +44.0% 85.54 US$3,966,493
2022-05-20 2022-05-20 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
381,841 +4.6%
2.23
US$850,742 		381,841 +4.6% 2.23 US$850,742
2022-05-20 2022-05-20 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
109,098 +4.8%
2.23
US$243,070 		109,098 +4.8% 2.23 US$243,070
2022-05-20 2022-05-20 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
54,549 +5.3%
2.23
US$121,535 		54,549 +5.3% 2.23 US$121,535
2022-05-20 2022-05-19 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
226,665 +2.8%
2.19
US$495,490 		226,665 +2.8% 2.19 US$495,490
2022-05-20 2022-05-19 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
64,762 +2.9%
2.19
US$141,570 		64,762 +2.9% 2.19 US$141,570
2022-05-20 2022-05-19 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
32,381 +3.3%
2.19
US$70,785 		32,381 +3.3% 2.19 US$70,785
2022-05-20 2022-05-18 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
121,590 +1.5%
1.96
US$238,560 		121,590 +1.5% 1.96 US$238,560
2022-05-20 2022-05-18 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
34,740 +1.6%
1.96
US$68,160 		34,740 +1.6% 1.96 US$68,160
2022-05-20 2022-05-18 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
17,370 +1.8%
1.96
US$34,080 		17,370 +1.8% 1.96 US$34,080
2022-03-15 2022-03-11 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
700,000 +9.7%
3.00
US$2,100,000 		700,000 +9.7% 3.00 US$2,100,000
2022-03-15 2022-03-11 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
200,000 +10.1%
3.00
US$600,000 		200,000 +10.1% 3.00 US$600,000
2022-03-15 2022-03-11 B Purchase
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
100,000 +11.5%
3.00
US$300,000 		100,000 +11.5% 3.00 US$300,000
2022-03-14 2022-03-09 B Purchase
Kilcoyne Adrian

Chief Medical Officer

Officer
5,000 +71.4%
2.78
US$13,900 		5,000 +71.4% 2.78 US$13,900
2022-03-14 2022-03-08 B Purchase
Kilcoyne Adrian

Chief Medical Officer

Officer
7,000 +inf%
2.53
US$17,710 		7,000 +inf% 2.53 US$17,710
2022-03-04 2022-03-02 B Purchase
Durrant Cameron

Chief Executive Officer

Executive Director
40,000 +133.3%
2.34
US$93,600 		40,000 +133.3% 2.34 US$93,600
2022-03-04 2022-03-02 B Purchase
Jordan Edward P.

Chief Commercial Officer

Officer
12,500 +inf%
2.32
US$29,000 		12,500 +inf% 2.32 US$29,000
2021-06-25 2021-06-25 PlS Planned sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
725,000 -8.1%
17.80
US$12,907,538 		725,000 -8.1% 17.80 US$12,907,538
2021-06-25 2021-06-25 PlS Planned sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
200,000 -8.2%
17.80
US$3,560,700 		200,000 -8.2% 17.80 US$3,560,700
2021-06-25 2021-06-25 PlS Planned sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
75,000 -7.2%
17.80
US$1,335,262 		75,000 -7.2% 17.80 US$1,335,262
2021-06-25 2021-06-24 PlS Planned sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
101,158 -1.1%
18.37
US$1,858,768 		101,158 -1.1% 18.37 US$1,858,768
2021-06-25 2021-06-24 PlS Planned sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
27,906 -1.1%
18.37
US$512,770 		27,906 -1.1% 18.37 US$512,770
2021-06-25 2021-06-24 PlS Planned sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
10,465 -1.0%
18.37
US$192,293 		10,465 -1.0% 18.37 US$192,293
2021-06-25 2021-06-23 PlS Planned sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
96,516 -1.1%
18.28
US$1,764,776 		96,516 -1.1% 18.28 US$1,764,776
2021-06-25 2021-06-23 PlS Planned sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
26,625 -1.1%
18.28
US$486,833 		26,625 -1.1% 18.28 US$486,833
2021-06-25 2021-06-23 PlS Planned sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
9,985 -0.9%
18.28
US$182,574 		9,985 -0.9% 18.28 US$182,574
2021-06-16 2021-06-14 S Sale
Durrant Cameron

Chief Executive Officer

Executive Director
49,906 -62.5%
20.61
US$1,028,563 		49,906 -62.5% 20.61 US$1,028,563
2021-06-16 2021-06-14 S Sale
Durrant Cameron

Chief Executive Officer

Executive Director
5,094 -6.0%
21.14
US$107,687 		5,094 -6.0% 21.14 US$107,687
2021-06-16 2021-06-14 S Sale
Durrant Cameron

Chief Executive Officer

Executive Director
26,441 -23.7%
20.60
US$544,685 		26,441 -23.7% 20.60 US$544,685
2021-06-09 2021-06-08 S Sale
Jordan Edward P.

Chief Commercial Officer

Officer
14,700 -100.0%
20.08
US$295,176 		14,700 -100.0% 20.08 US$295,176
2021-06-09 2021-06-07 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
42,440 -0.4%
19.08
US$809,891 		42,440 -0.4% 19.08 US$809,891
2021-06-09 2021-06-07 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
25,464 -1.0%
19.08
US$485,935 		25,464 -1.0% 19.08 US$485,935
2021-06-09 2021-06-07 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
12,732 -1.1%
19.08
US$242,967 		12,732 -1.1% 19.08 US$242,967
2021-06-04 2021-06-04 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
66,886 -0.7%
18.46
US$1,234,950 		66,886 -0.7% 18.46 US$1,234,950
2021-06-04 2021-06-04 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
40,132 -1.5%
18.46
US$740,977 		40,132 -1.5% 18.46 US$740,977
2021-06-04 2021-06-04 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
20,066 -1.7%
18.46
US$370,489 		20,066 -1.7% 18.46 US$370,489
2021-06-04 2021-06-03 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
100,607 -1.0%
18.37
US$1,848,050 		100,607 -1.0% 18.37 US$1,848,050
2021-06-04 2021-06-03 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
60,365 -2.2%
18.37
US$1,108,845 		60,365 -2.2% 18.37 US$1,108,845
2021-06-04 2021-06-03 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
30,182 -2.5%
18.37
US$554,413 		30,182 -2.5% 18.37 US$554,413
2021-06-04 2021-06-02 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
40,042 -0.4%
19.01
US$761,258 		40,042 -0.4% 19.01 US$761,258
2021-06-04 2021-06-02 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
24,056 -0.9%
19.01
US$457,341 		24,056 -0.9% 19.01 US$457,341
2021-06-04 2021-06-02 S Sale
Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
12,028 -1.0%
19.01
US$228,670 		12,028 -1.0% 19.01 US$228,670
2021-03-11 2021-03-11 S Sale
NOMIS BAY LTD.
Large shareholder
119,201 -2.2%
16.02
US$1,909,672 		119,201 -2.2% 16.02 US$1,909,672
2021-03-11 2021-03-10 S Sale
NOMIS BAY LTD.
Large shareholder
32,469 -0.6%
16.46
US$534,589 		32,469 -0.6% 16.46 US$534,589
2021-03-11 2021-03-09 S Sale
NOMIS BAY LTD.
Large shareholder
83,568 -0.1%
17.24
US$1,440,495 		83,568 -0.1% 17.24 US$1,440,495
2021-03-01 2021-03-01 S Sale
NOMIS BAY LTD.
Large shareholder
14,100 -0.3%
18.65
US$262,951 		14,100 -0.3% 18.65 US$262,951
2021-03-01 2021-02-26 S Sale
NOMIS BAY LTD.
Large shareholder
30,003 -0.5%
19.18
US$575,437 		30,003 -0.5% 19.18 US$575,437
2021-03-01 2021-02-25 S Sale
NOMIS BAY LTD.
Large shareholder
2,402 -0.0%
19.17
US$46,045 		2,402 -0.0% 19.17 US$46,045
2021-02-24 2021-02-24 S Sale
NOMIS BAY LTD.
Large shareholder
25,906 -0.5%
19.55
US$506,333 		25,906 -0.5% 19.55 US$506,333
2021-02-24 2021-02-22 S Sale
NOMIS BAY LTD.
Large shareholder
77,314 -1.3%
23.21
US$1,794,690 		77,314 -1.3% 23.21 US$1,794,690
2021-02-19 2021-02-19 S Sale
NOMIS BAY LTD.
Large shareholder
37,300 -0.6%
23.50
US$876,364 		37,300 -0.6% 23.50 US$876,364
2021-02-19 2021-02-18 S Sale
NOMIS BAY LTD.
Large shareholder
42,408 -0.7%
21.70
US$920,042 		42,408 -0.7% 21.70 US$920,042
2021-02-19 2021-02-17 S Sale
NOMIS BAY LTD.
Large shareholder
9,700 -0.2%
19.92
US$193,214 		9,700 -0.2% 19.92 US$193,214
2021-02-16 2021-02-13 S Sale
NOMIS BAY LTD.
Large shareholder
16,423 -0.3%
19.68
US$323,221 		16,423 -0.3% 19.68 US$323,221
2021-02-16 2021-02-11 S Sale
NOMIS BAY LTD.
Large shareholder
550 -0.0%
21.01
US$11,555 		550 -0.0% 21.01 US$11,555
2021-02-10 2021-02-10 S Sale
NOMIS BAY LTD.
Large shareholder
10,875 -0.2%
21.39
US$232,605 		10,875 -0.2% 21.39 US$232,605
2021-02-10 2021-02-09 S Sale
NOMIS BAY LTD.
Large shareholder
25,666 -0.4%
22.32
US$572,942 		25,666 -0.4% 22.32 US$572,942
2021-02-10 2021-02-08 S Sale
NOMIS BAY LTD.
Large shareholder
17,732 -0.3%
20.70
US$367,035 		17,732 -0.3% 20.70 US$367,035
2021-02-04 2021-02-04 S Sale
NOMIS BAY LTD.
Large shareholder
47,862 -0.8%
21.88
US$1,047,077 		47,862 -0.8% 21.88 US$1,047,077
2021-02-04 2021-02-03 S Sale
NOMIS BAY LTD.
Large shareholder
25,000 -0.4%
19.23
US$480,825 		25,000 -0.4% 19.23 US$480,825
2021-02-04 2021-02-02 S Sale
NOMIS BAY LTD.
Large shareholder
722 -0.0%
20.03
US$14,461 		722 -0.0% 20.03 US$14,461
2021-01-27 2021-01-25 S Sale
NOMIS BAY LTD.
Large shareholder
23,140 -0.4%
19.23
US$445,028 		23,140 -0.4% 19.23 US$445,028
2021-01-27 2021-01-22 S Sale
NOMIS BAY LTD.
Large shareholder
71,892 -1.2%
20.08
US$1,443,304 		71,892 -1.2% 20.08 US$1,443,304
2021-01-21 2021-01-20 S Sale
NOMIS BAY LTD.
Large shareholder
2,500 -0.0%
18.37
US$45,928 		2,500 -0.0% 18.37 US$45,928
2021-01-21 2021-01-19 S Sale
NOMIS BAY LTD.
Large shareholder
6,000 -0.1%
21.08
US$126,495 		6,000 -0.1% 21.08 US$126,495
2021-01-19 2021-01-19 S Sale
NOMIS BAY LTD.
Large shareholder
50,000 -0.8%
19.81
US$990,500 		50,000 -0.8% 19.81 US$990,500
2021-01-19 2021-01-15 S Sale
NOMIS BAY LTD.
Large shareholder
30,000 -0.5%
18.23
US$546,870 		30,000 -0.5% 18.23 US$546,870
2021-01-19 2021-01-14 S Sale
NOMIS BAY LTD.
Large shareholder
25,000 -0.4%
18.07
US$451,650 		25,000 -0.4% 18.07 US$451,650
2021-01-13 2021-01-12 S Sale
NOMIS BAY LTD.
Large shareholder
14,577 -0.2%
18.43
US$268,613 		14,577 -0.2% 18.43 US$268,613
2021-01-13 2021-01-11 S Sale
NOMIS BAY LTD.
Large shareholder
10,423 -0.2%
19.00
US$198,037 		10,423 -0.2% 19.00 US$198,037
2020-12-28 2020-12-24 S Sale
NOMIS BAY LTD.
Large shareholder
8,401 -0.1%
22.05
US$185,234 		8,401 -0.1% 22.05 US$185,234
2020-12-28 2020-12-23 S Sale
NOMIS BAY LTD.
Large shareholder
45,000 -0.7%
21.09
US$948,870 		45,000 -0.7% 21.09 US$948,870
2020-12-23 2020-12-22 S Sale
NOMIS BAY LTD.
Large shareholder
50,000 -0.8%
50,000.00
US$2,500,000,000 		50,000 -0.8% 50,000.00 US$2,500,000,000
Explore more

More insider trading research around Humanigen Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America